Cargando…
Pregnane × Receptor (PXR) expression in colorectal cancer cells restricts irinotecan chemosensitivity through enhanced SN-38 glucuronidation
BACKGROUND: Clinical efficacy of chemotherapy in colorectal cancer is subjected to broad inter-individual variations leading to the inability to predict outcome and toxicity. The topoisomerase I inhibitor irinotecan (CPT-11) is worldwide approved for the treatment of metastatic colorectal cancer and...
Autores principales: | Raynal, Caroline, Pascussi, Jean-Marc, Leguelinel, Géraldine, Breuker, Cyril, Kantar, Jovana, Lallemant, Benjamin, Poujol, Sylvain, Bonnans, Caroline, Joubert, Dominique, Hollande, Frédéric, Lumbroso, Serge, Brouillet, Jean-Paul, Evrard, Alexandre |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2838814/ https://www.ncbi.nlm.nih.gov/pubmed/20196838 http://dx.doi.org/10.1186/1476-4598-9-46 |
Ejemplares similares
-
Clinical relevance of nine transcriptional molecular markers for the diagnosis of head and neck squamous cell carcinoma in tissue and saliva rinse
por: Lallemant, Benjamin, et al.
Publicado: (2009) -
Reference gene selection for head and neck squamous cell carcinoma gene expression studies
por: Lallemant, Benjamin, et al.
Publicado: (2009) -
Marine Ligands of the Pregnane X Receptor (PXR): An Overview
por: Carazo, Alejandro, et al.
Publicado: (2019) -
Pregnane X Receptor (PXR) Polymorphisms and Cancer Treatment
por: Skandalaki, Aikaterini, et al.
Publicado: (2021) -
The role of pregnane X receptor (PXR) in substance metabolism
por: Lv, Ye, et al.
Publicado: (2022)